The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema

NCT02718547 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2017-03-28

No results posted yet for this study

Summary

The Investigators propose to examine the effect of lowering the intraocular pressure on macular edema in Participants diagnosed with diabetic macular edema. Our theory is based on the assumption that lower intraocular pressure means higher Ocular Perfusion pressure, which may cause an improvement in retinal perfusion and thus an improvement in retinal oxygenation and reduced edema

Conditions

  • Complications of Diabetes Mellitus

Interventions

DRUG

Combigan

Each Participant will be instructed to instill Combigan eye drops twice daily in one of his eyes (randomly chosen)

Sponsors & Collaborators

  • Meir Hospital, Kfar Saba, Israel

    collaborator OTHER
  • Meir Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-26
Primary Completion
2018-03-30
Completion
2018-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02718547 on ClinicalTrials.gov